The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

GALLIMUNE 303 ND+IB+ART Emulsion for injection

Boehringer Ingelheim Vetmedica GmbHVPA10454/052/001

Main Information

Trade NameGALLIMUNE 303 ND+IB+ART Emulsion for injection
Active SubstancesInactivated newcastle disease virus, ulster 2c strain
Inactivated infectious bronchitis virus, mass41 strain
Inactivated avian rhinotracheitis virus (swollen head syndrome), vco3 strain
Dosage FormEmulsion for injection
Licence HolderBoehringer Ingelheim Vetmedica GmbH
License Holder AddressBinger Strasse 173
55216 Ingelheim am Rhein
Licence NumberVPA10454/052/001

Group Information

ATC CodeQI01AA21 avian infectious bronchitis virus + newcastle disease virus / paramyxovirus + avian rhinotracheitis virus
Therapeutic ClassImmunological - Inactivated Vaccine


License statusAuthorised
Licence Issued25/11/2005
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back